Antimalarial activity of cryptolepine and isocryptolepine, alkaloids isolated from Cryptolepis sanguinolenta

Phytotherapy Research

Volumn 10, Issue 4, 1996, Pages 317-321

  Grellier, Philippe ^a   Ramiaramanana, Lobo ^a   Millerioux, Valérie ^a   Deharo, Eric ^a   Schrével, Joseph ^a   Frappier, François ^a   Trigalo, François ^a   Bodo, Bernard ^a   Pousset, Jean Louis ^a  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

Author keywords

cryptolepine; Cryptolepis sanguinolenta; isocryptolepine; malaria; Plasmodium falciparum

Indexed keywords

ALKALOID; CHLOROQUINE; CRYPTOLEPINE; ISOCRYPTOLEPINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; DRUG SYNTHESIS; INTRAPERITONEAL DRUG ADMINISTRATION; MALARIA; MALE; MOUSE; NONHUMAN; PARASITEMIA; PLANT ROOT; PLASMODIUM FALCIPARUM;

EID: 0029922547     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199606)10:4<317::AID-PTR858>3.0.CO;2-0     Document Type: Article

References (25)

1. Atwal, M. S., Bauer, L, Dixit, S. N., Gehrien, J. E., and Morris, R. W. (1965). Analgesics. Some substituted 2,3-dihydro-4-quinolones. J. Med. Chem. 8, 566-571.
2. Bamgbose, S. O. A., and Noamesi, B. K. (1981). Studies on cryptolepine II: Inhibition of carrageenan-induced oedema by cryptolepine. Planta Med. 41, 392-396.
3. Beauté-Lafitte, A., Altemayer-Caillard, V., Gonnet-Gonzalez, F., Ramiaramanana, L., Chabaud, A. G., and Landau, I. (1994). The chemosensitivity of the rodent malaria. Relationships with the biology of merozoites. Int. J. Parasitol. 24, 981-986.
4. Boakye-Yiadom, K., and Heman-Ackah, S. M. (1979). Cryptolepine hydrochloride: effect on Staphylococcus aureus. J. Pharm. Sci 68, 1510-1514.
5. Boye, G. L., and Oku-Ampofo. (1983). Proceedings of the First International Symposium on Cryptolepine. Kumasi, Ghana, University of Science and Technology.
6. Caillard, V., Beauté-Lafitte, A., Chabaud, A. G., and Landau, I. (1992). Plasmodium vinckei petteri: identification of the stages sensitive to artemether. Exp. Parasitol. 75, 449-456.
7. Clinquart, Ed. (1929). Sur la composition chimique de Cryptolepis triangularis. plante congolaise. Bull. l'Académie Royale de Médecine de Belgique 9, 627-635.
8. Desjardins, R. E., Canfield, C. J., Haynes, J. D., and Chulay, J. D. (1979). Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16, 710-718.
9. Dwuma-Badu, D., Ayim, J. S. K., Fiagbe, N. I. Y., Knapp, J. E., Schiff, P. L. Jr., and Slatkin, D. J. (1978). Constituents of West African medicinal plants XX: Quindoline from Cryptolepis sanguinolenta, J. Pharm. Sci. 67, 433-434.
10. Gellert, E., Raymond-Hamet, and Schlittier, E. (1951). The use of the plant Cryptolepis sanguinolenta in folklore medicine., Helv. Chim. Acta 34, 642.
11. Kirby, G. C., Noamesi, B. K., Paine, A., Warhurst, D. C., and Phillipson, J. D. (1992). Antimalarial activity in vivo of cryptolepine. Trans. Roy. Soc. Trop. Med. Hyg. 86, 343.
12. Landau, I., Chabaud, A. G., Cambie, G., and Ginsburg, H. (1991). Chronotherapy of malaria: an approach to malaria chemotherapy. Parasitology Today 7, 350-352.
13. Noamesi, B. K., and Bamgbose, S. O. A. (1982). Preferential blockade of pre-synaptic alpha-adrenoceptors on the rat isolated vas deferens by cryptolepine, 7: Studies on cryptolepine. Planta Med 44, 241-245.
14. Noamesi, B. K., Paine, A., Kirby, G. C., Warhurst, D. C., and Phillipson, J. D. (1991). In vitro antimalarial activity of cryptolepine, an indoio-quinoline Trans. Roy. Soc. Trop. Med. Hyg. 85, 315.
15. Oliver-Bever, B. E. P. (1986). Medicinal Plants in Tropical West Africa. Cambridge University Press, Cambridge.
16. Oyekan, O. A., Botting, J. H., and Noamesi, B. K. (1988). Cryptolepine inhibits platelet aggregation in vitro and in vivo and stimulates fibrinolysis ex vivo. Gen. Pharmac. 19, 233-237.
17. Peters, W. (1980). Chemotherapy and Drug Resistance in Malaria, Vol. 1, 2nd edn, p. 113. Academic Press, London.
18. Pousset, J. L., Martin, M. T., Jossang, A., and Bodo, B. (1995). Isocryptolepine, an alkaloid from Cryptolepis sanguinolenta. Phytochemistry, 39, 735-736.
19. Raymond-Hamet. (1937). Quelques propriétés physiologiques des alcaloïdes du Cryptolepis sanguinolenta Schlechter. Comp. Rend. Soc. Biol. 126, 768-770.
20. Raymond-Hamet. (1938). Les effets hypotenseurs et vasodilateurs de la cryptolépine, Comp. Rend. Soc. Biol. 207, 1016-1018.
21. Rogers, C. V., and Corson, B. B. (1963). 1,2,3,4 tetahydrocarbazole. Org. Synth. Coll. Vol. IV, 884-886.
22. Saxton, J. E. (1965). In The Alkaloids, Chemistry and Physiology, Vol. 8, ed. by R. H. F. Manske and H. L. Holmes pp. 19-25. Academic Press, New York.
23. Sofowora, A. (1982). Medicinal Plants and Traditional Medicine in Africa, John Wiley, Chichester.
24. Tackie, A. N., Boye, G. L., Sharaf, M. H. M. et al. (1993). Cryptospirolepine, a unique spiro-nonacyclic alkaloid isolated from Crypotolepis sanguinolenta. J. Nat. Prod. 56, 653-670.
25. Trager, W., and Jensen, J. B. (1976). Human malarial parasites in continuous culture. Science 193, 673-675.